[1]HYUNA S,JACQUES F,REBECCA L,et al.Global cancer statistics 2020:GLOB-OCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2021,71(3):209-249.
[2]CHEN M,ZHANG L,LIU X,et al.PER1 is a prognostic biomarker and correla-ted with immune infiltrates in ovarian cancer[J].Front Genet,2021,12:697471.
[3]LI HX.The role of circadian clock genes in tumors[J].Onco Targets Ther,2019,12:3645-3660.
[4]周湾,罗盼,曾艳,等.鼻咽癌CNE2细胞生物钟基因Per1表达及其对生物学行为影响的研究[J].中华肿瘤防治杂志,2022,29(11):800-808.
ZHOU W,LUO P,ZENG Y,et al.Study on the expression of Per1 gene in CNE2 cells of nasopharyngeal carcinoma and its effect on biological behavior[J].Chinese Journal of Cancer Prevention and Treatment,2022,29(11):800-808.
[5]YANG C,REN J,LI B,et al.Identificationof clinical tumor stages related mRNAs and miRNAs in cervical squamous cell carcinoma[J].Pathol Res Pract,2018,214(10):1638-1647.
[6]XU J,ZHANG L,LI N,et al.Etomidate elicits anti-tumor capacity by disrupting the JAK2/STAT3 signaling pathway in hepatocellular carcinoma[J].Cancer Lett,2023,552:215970.
[7]WANG S,SHEN M,WEN X,et al.Correlation of the expressions of IGF1-RR-ACK1-STAT3 and Bcl-xl in nasopharyngeal carcinoma with the clinicopathological features and prognosis of nasopharyngeal carcinoma[J].J Cell Biochem,2018,119( 2) :1931-1941.
[8]逄明杰,胡文婷,王宁宁,等.JAK2和STAT3在鼻咽癌中的表达及其与临床病理特征和预后的关系[J].现代肿瘤医学,2018,26(23):3743-3748.
PANG MJ,HU WT,WANG NN,et al.JAK2 and STAT3 in nasopharyngeal carcinoma and their relationship with clinicopathological features and prognosis[J].Modern Oncology,2018,26(23):3743-3748.
[9]MENGIE AYELE T,TILAHUN MUCHE Z,BEHAILE TEKLEMARIAM A,et al.Role of JAK2/STAT3 signaling pathway in the tumorigenesis,chemotherapy resistance,and treatment of solid tumors:A systemic review[J].J Inflamm Res,2022,15:1349-1364.
[10]YE Z,CHEN X,CHEN X.ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition[J].Oncology Letters,2018,15(2):1511-1516.
[11]WANG X,LI X,WANG Z,et al.lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation,apoptosis and EMT processes[J].Oncol Rep,2021,45(4):40.
[12]WANG Z,WANG H,WANG Z,et al.Associated analysis of Per1/TUBB2B with endometrial cancer development caused by circadian rhythm disorders[J].Med Oncol,2020,37(10):90.
[13]GUO X,LI K,JIANG W,et al.RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of Per1 in an m6A-YTHDF2-dependent manner[J].Mol Cancer,2020,19(1):91.
[14]YANG G,YANG Y,TANG H,et al.Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway[J].Cancer Sci,2020,111(5):1542-1554.
[15]LIU JF,DENGWW,CHEN L,et al.Inhibition of JAK2-STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer[J].Mol Carcinog,2018,57(3):429 -439.
[16]WANG Y,SHEN SY,LIU L,et al.Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway[J].J Ethnopharmacol,2022,282:114581.
[17]PARK SY,LEE CJ,CHOI JH,et al.The JAK2/STAT3/CCND2 Axis promotes colorectal cancer stem cell persistence and radioresistance[J].J Exp Clin Cancer Res,2019,38(1):399.
[18]LI N,MAO D,CAO Y,et al.Downregulation of SIRT6 by miR-34c-5p is associated with poor prognoeusis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2/STAT3 signaling pathway[J].Int J Oncol,2018,52(5):1515-1527.
[19]SONG Q,LIU B,LI X,et al.MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGβ8- JAK2/STAT3 axis[J].Biochem Biophys Res Commun,2018,501(2):494-500.
[20]RIZZO A,BRANDI G.Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma[J].Cancer Treat Res Commun,2021,27:100328.